UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025699
Receipt number R000029565
Scientific Title Effect of Lutein, Zeaxanthin supplements on human.
Date of disclosure of the study information 2018/03/15
Last modified on 2018/07/09 13:26:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Lutein, Zeaxanthin supplements on human.

Acronym

Lutein Zeaxanthin clinical trial

Scientific Title

Effect of Lutein, Zeaxanthin supplements on human.

Scientific Title:Acronym

Lutein Zeaxanthin clinical trial

Region

Japan


Condition

Condition

Healthy people

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effect of Lutein, Zeaxanthin supplements on human.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

contrast sensitivity
Accommodation ability

Key secondary outcomes

Visual Analog Scale


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Lutein,Zeaxanthin supplements
2 capsule/day

Interventions/Control_2

Placebo supplements
2 capsule/day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) persons who will generally be judged as healthy
(2) Persons who will give written informed consent by theirselves

Key exclusion criteria

(1) persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficay with the effect evaluated in this study
(2) persons who changed their habitats of supplements whitin 4 weeks.
(3) Persons who work in night shift or in day and night shift
(4) persons who have been treated their illness or prevention in a clinic at their informed consent
(5) persons with their medical histories as follows: serious diseases of Sugar metabolism,lipid metabolism, liver function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system
(6) persons with the medical histories of alcoholism or drug dependence
(7) persons who might be developed allergic reaction to foods.
(8) Persons who are pregnant, breast-feeding, or hope to be pregnant during the study preiod
(9) persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device)
(10) persons who will not be judged suitable to the participants by the investigator.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kuniyoshi Shimizu

Organization

Faculty of Agriculture, Kyushu University

Division name

Laboratory of Systematic Forest and Forest Products Science

Zip code


Address

6-10-1 Hakozaki, Higashi-ku, Fukuoka

TEL

092-642-3002

Email

shimizu@agr.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kuniyoshi Shimizu

Organization

Faculty of Agriculture, Kyushu University

Division name

Laboratory of Systematic Forest and Forest Products Science

Zip code


Address

6-10-1 Hakozaki, Higashi-ku, Fukuoka

TEL

092-642-3002

Homepage URL


Email

shimizu@agr.kyushu-u.ac.jp


Sponsor or person

Institute

Laboratory of Systematic Forest and Forest Products Science, Faculty of Agriculture, Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Stella Sasaki Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Fuculuty of Humanity-Oriented Science and Eingineering, Kindai University

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 11 Month 28 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 16 Day

Last follow-up date

2017 Year 03 Month 25 Day

Date of closure to data entry

2017 Year 04 Month 07 Day

Date trial data considered complete

2017 Year 04 Month 26 Day

Date analysis concluded

2017 Year 05 Month 29 Day


Other

Other related information



Management information

Registered date

2017 Year 01 Month 16 Day

Last modified on

2018 Year 07 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029565


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name